COSM · Cosmos Health Inc. · Executive Compensation
$0.27
+0.02 (+6.02%)
At close · Sep 14
Going-concern doubt
— flagged Aug 18, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions raise substantial doubt about the Company's ability to continue as a going concern for a period of 12 months from the date of this filing.”View the 10-Q filed Aug 18, 2026
Market Cap
$26.44M
Shares
100.63M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Theodoros C. Karkantzos | director | Appointed | 2026-07-16 |
| Dr. Anastasios Aslidis | director | Appointed | 2026-07-16 |
| Suhel Bhutawala | director | Appointed | 2026-07-16 |
| John J. Hoidas | director | Appointed | 2026-07-16 |
| Demetrios G. Demetriades | director | Appointed | 2026-07-16 |
| Grigorios Siokas | director | Appointed | 2026-07-16 |
| Theodoros C. Karkantzos | member of the Board | Appointed | 2025-10-06 |
| Theodoros C. Karkantzos | director | Appointed | 2025-10-01 |
| Suhel Bhutawala | director | Appointed | 2025-10-01 |
| John J. Hoidas | director | Appointed | 2025-10-01 |
| Dr. Anastasios Aslidis | director | Appointed | 2025-10-01 |
| Demetrios G. Demetriades | director | Appointed | 2025-10-01 |
| Grigorios Siokas | director | Appointed | 2025-10-01 |